Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Dynavax hepatitis B vaccine works; raises safety issues: FDA

      Dynavax hepatitis B vaccine works; raises safety issues: FDA

      Ruby Khatun Khatun29 July 2017 9:09 AM IST
      Dynavax Technologies Corp's experimental hepatitis B vaccine is effective, but there were more deaths and serious heart problems in patients given the...
      As drug prices drop, generics makers fight back with deals

      As drug prices drop, generics makers fight back with deals

      Ruby Khatun Khatun28 July 2017 8:11 PM IST
      NEW YORK: Generic drug makers are turning to M&A to shield themselves against a concerted effort by U.S. regulators to crack down on steep drug...
      Amgen gets fast FDA review for adding heart benefits to cholesterol drug label

      Amgen gets fast FDA review for adding heart benefits to cholesterol drug label

      Ruby Khatun Khatun28 July 2017 9:40 AM IST
      Amgen Inc said on Thursday the U.S. Food and Drug Administration granted priority review to the company's request to add important heart safety data...
      Patanjali, Uttarakhand government to work together

      Patanjali, Uttarakhand government to work together

      Ruby Khatun Khatun28 July 2017 9:35 AM IST
      DEHRADUN: Yoga guru Baba Ramdev-led Patanjali Ayurved and Uttarakhand government have decided to collaborate to promote organic farming, tourism and...
      1mg raises Rs 100 crore in series C funding by HBM Healthcare

      1mg raises Rs 100 crore in series C funding by HBM Healthcare

      Ruby Khatun Khatun28 July 2017 9:30 AM IST
      Bengaluru: 1mg Technologies Pvt Ltd, India’s largest digital health platform which operates mobile app “1mg” on Android/ iOS and the web platform...
      Mylan launches tablets for treatment of Hepatitis C in India

      Mylan launches tablets for treatment of Hepatitis C in India

      Ruby Khatun Khatun28 July 2017 9:30 AM IST
      HERTFORDSHIRE, England and PITTSBURGH: Mylan Pharmaceuticals Private Limited (a subsidiary of Mylan N.V.) announced the launch of Velpatasvir 100...
      GSK gets FDA approval for Arnuity Ellipta in the US for the treatment of asthma

      GSK gets FDA approval for Arnuity Ellipta in the US for the treatment of asthma

      Ruby Khatun Khatun28 July 2017 9:21 AM IST
      London: GlaxoSmithKline plc (GSK) announced that the FDA has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled...
      Unichem Labs gets USFDA nod for hypertension drug

      Unichem Labs gets USFDA nod for hypertension drug

      Ruby Khatun Khatun28 July 2017 9:20 AM IST
      New Delhi: Unichem Laboratories has received approval from the US health regulator for losartan potassium and hydrochlorothiazide tablets, used in the...
      DocsApp launches night-time child specialist online consultation

      DocsApp launches night-time child specialist online consultation

      Ruby Khatun Khatun28 July 2017 9:15 AM IST
      New Delhi: Adding to the high-quality healthcare services it offers, DocsApp, a chat based healthcare platform that connects patients to specialist...
      GSK Q1 net down 63% at Rs 26 crore on GST transition

      GSK Q1 net down 63% at Rs 26 crore on GST transition

      Ruby Khatun Khatun27 July 2017 9:20 AM IST
      New Delhi: GlaxoSmithKline Pharmaceuticals (GSK) on Tuesday reported 63.44 per cent decline in standalone net profit to Rs 26.42 crore for the first...
      Merck, Samsung Bioepis launch discounted US Remicade alternative

      Merck, Samsung Bioepis launch discounted US Remicade alternative

      Ruby Khatun Khatun27 July 2017 9:19 AM IST
      NEW YORK/SEOUL: Merck & Co and South Korea's Samsung Bioepis Co Ltd said on Monday they have begun selling a less expensive alternative version of...
      Glenmark Pharma gets USFDA approval for skin cream generic

      Glenmark Pharma gets USFDA approval for skin cream generic

      Ruby Khatun Khatun27 July 2017 9:18 AM IST
      New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Desonide cream, used to treat a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok